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Polygalae Radix is an important medicinal plant that is widely used in most of Africa. 3,4,5-
Trimethoxycinnamic acid (TMCA) is one of the constituents of Polygalae Radix. Until now, the mecha-
nisms involved in the anti-seizure property of TMCA are still unclear. We examined the anti-seizure
effect of TMCA. TMCA administered at doses of 5, 10 and 20 mg/kg and evaluated anti-seizure effects
by maximal electroshock (MES) and pentylenetetrazol (PTZ) models in mice. TMCA administered at
doses of 10 and 20 mg/kg signiﬁcantly reduced the incidence of MES-induced tonic hindlimb extension
(THE). TMCA signiﬁcantly delayed the onset of myoclonic jerks (MJ), and decreased the seizure severity
and mortality compared with the vehicle-treated animals in PTZ seizure model. TMCA 10 and 20 mg/kg
treated groups also did not determined generalized clonic seizures (GCS).
Pretreatment with a GABAA/benzodiazepine (BZ) receptor antagonist ﬂumazenil blocked the anti-
seizure effects of TMCA. These data support the further investigation of TMCA as a GABAA/BZ receptor
agonist for anti-seizure therapy.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Epilepsy is one of the most common and heterogeneous
neurological disorders (1). It has been reported that more than 50
million people worldwide suffer from epilepsy, current anti-
epileptic drugs are only effective in 60e70% of individuals (2).
Anti-epileptic drugs used to treat epilepsy can cause severe, life
threatening side effects. BZs are highly prescribed anti-epileptic
drugs and of great clinical signiﬁcance; however, the develop-
ment of tolerance restricts their usefulness (3). A number of newer
anti-epileptic drugs have been developed in the last few years to
improve the treatment outcomes in epilepsy (4). But resistance to
anti-epileptic drugs as well as intolerability led to serious demands
for developing new drugs for epilepsy treatment (5).
In traditional Chinese medicine, Radix Polygalae (the root of
Polygala tenuifolia) have been known to be an important herb that. Chen).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).exhibits sedative effects in insomnia, and is widely used as an
tranquillizer (6). 3,4,5-Trimethoxycinnamic acid (TMCA), one of the
constituents of Polygalae Radix, has been reported prolonged
sleeping time induced by pentobarbital or decreased by stress (7,8).
Furthermore, TMCA also could decrease the locomotor activity in
mice (7). The current study was conducted to investigate the anti-
seizure properties of TMCA in the PTZ- and maximal electroshock-
induced seizure models and to investigate mechanisms underlying
the anti-seizure property of TMCA. The GABAA receptors are Cl
channel selective ligand-gated ion channels that mediate fast in-
hibition in the CNS and are important targets for benzodiazepines
(BZs) (9). BZ binding with GABAA receptor complex, enhancing Cl
channel conductance primarily by increasing the frequency of re-
ceptor channel opening (10,11). The GABAA receptor g subunit, in
particular g2 subunit is essential for the formation of the binding
site, binding efﬁcacy for BZ (9,12,13). TMCA increased Cl channel
inﬂux and the expressions of g-subunit of GABAA receptors in the
cerebellar granule cells (7). These ﬁndings suggest that TMCA
might have important effect on GABAergic system.
The current study was conducted to investigate the anti-seizure
properties of TMCA in the PTZ and the maximal electroshocknese Pharmacological Society. This is an open access article under the CC BY-NC-ND
Fig. 1. Incidence of tonic extension (%) after treatment with TMCA and diazepam in the
MES model. Each value represents the incidence of tonic hindlimb extension (THE) as a
percentage (n ¼ 10). **P < 0.01, compared with the control group (Fisher's exact test
followed by bonferroni for correction).
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the anti-seizure property of TMCA. We showed that TMCA exerted
an anti-seizure activity. These effects were attenuated by pre-
treatment with ﬂumazenil, a BZ receptor antagonist. The above
studies suggest that TMCA may exert anti-seizure activity by acting
at the GABAA/BZ receptor complex.
2. Materials and methods
2.1. Animals
Ault male KunMing-strain mice (Experimental Animal Center,
Fudan University, Shanghai, China) weighing 18e20 g were used.
Animals were housed in cages at room temperature on a 12: 12 h
day/night cycle and given ad libitum access to food and water. On
days prior to seizure induction, animals were habituated to the test
environment.
The experimental protocols were approved by the Committee
on the Ethics of Animal Experiments of the University of Fudan,
Shanghai Medical College (Permit Number: 20110307e049).
2.2. Drugs
TMCA, PTZ and ﬂumazenil were purchased from SigmaeAldrich
Co. (St Louis, MO, USA), dissolved in saline containing 0.5% dime-
thylsulfoxide (DMSO), and administrated intraperitoneally (i.p.) in
a constant volume of 10 ml/kg. The dosage selections, route of drug
administration, and injection time of different compounds were
based on preliminary experiments and pharmacokinetic consider-
ations (7,14).
2.3. Seizure models
2.3.1. Maximal electroshock seizure (MES) method
The MES method produces reproducible tonic convulsion
characterized by tonic hindlimb extension (THE). THE is the hin-
dlimbs of animals outstretched 180to the plane of the body (15).
Electroconvulsions were produced by a current (ﬁxed current in-
tensity of 70 mA, 0.4 s stimulus duration), delivered by an electric
stimulator (2-MU-2; Shanghai Medical College, China) (16,17). For
the control (vehicle) group, animals received vehicle. For the pos-
itive control group, animals received diazepam (2 mg/kg, i.p.). For
the test groups, mice were respectively injected with TMCA at 5, 10,
20 mg/kg. Thirty minutes later all the mice were treated with
electrical stimulation. Animals were considered protected if they
did not exhibit THE. The protective efﬁcacy of TMCA was deter-
mined as ability to protect 50% of animals against the maximal
electroshock-induced THE and expressed as respective values of the
median effective dose (ED50) (18).
2.4. PTZ-induced convulsion
Animals were placed individually in Plexiglas boxes and seizure
behaviors were observed for 60 min after PTZ injection (60 mg/kg,
i.p.). The seizure behavior was evaluated as follows (14,17,19,20):
Stage 0, no response; Stage 1, ear and facial twitching; Stage 2,
myoclonic jerks (MJ); Stage 3, clonic forelimb convulsions; Stage 4,
generalized clonic seizures (GCS), with turning to a side position;
and Stage 5, generalized clonic-tonic seizures (GTCS) or death
within 60min. Latency to the onset of MJ and GCS, the seizure stage
were measured. The mice were divided into 5 groups and were
injected i.p. with vehicle, TMCA at a dose of 5, 10, 20 mg/kg and
diazepam 2 mg/kg; and 30 min later were injected with PTZ
(60 mg/kg, i.p.).2.5. Study on receptor mechanism involved in anti-seizure effects of
TMCA
Flumazenil was chosen to probe the role of the GABAA/BZ re-
ceptors in the anti-seizure effects of TMCA. Flumazenil 1 and 5 mg/
kg was given 60 min before TMCA administration. The mice were
given TMCA 20 mg/kg 30 min before PTZ injection or exposition for
MES procedure.2.6. Statistical analysis
All datawere expressed as themean ± S.E.M. (n¼ 5e10). Seizure
stages were evaluated by using the KruskaleWallis test followed by
Nemenyi. For parametric data, single comparisons were tested
using the t-test, whereasmultiple comparisons among groupswere
analyzed using one-way or two-way ANOVA followed by LSD's test.
Fisher's exact test followed by bonferroni was used to determine
the overall differences in the incidence of THE due to convulsions.
All statistical analyses were carried out by using SPSS 17.0 for
Windows. P < 0.05 was considered as statistically signiﬁcant.3. Results
3.1. Anti-seizure property of TMCA
The protective effect of TMCA against maximal electroshock
seizure (MES)-induced THE was observed 30 min after TMCA
administration. In the control group, 100% of the mice exhibited
THE. The tonic ﬂexion of the limbs occurred immediately after the
shock and progressed into tonic extension of the hind limbs fol-
lowed by stupor and recovery. TMCA given at 10 and 20 mg/kg
signiﬁcantly decreased the incidence of MES-induced THE to 50%
and 20% of the value of the vehicle controls (n ¼ 10, Fig. 1). How-
ever, TMCA given at 5 mg/kg decreased the incidence of MES-
induced THE to only 80%. The ED50 for the anti-convulsion effect
of TMCA was 10 mg/kg. No mice died in both vehicle- and TMCA-
treated groups. Diazepam as a positive control signiﬁcantly
decreased the incidence of MES-induced THE to 10%. However, we
did not observed any prolongation on duration of THE induced by
TMCA. These results indicate that TMCA given at 10 and 20 mg/kg
doses has potent anti-seizure effects against MES-induced seizures.
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in the MES model
To further investigate the role of GABAA/BZ receptor in the anti-
seizure property of TMCA, we administrated GABAA/BZ receptor
antagonist ﬂumazenil. We found that 100% of the mice exhibited
MES-induced THE in the vehicle treated group. When mice were
injected with TMCA at 20 mg/kg, only 20% of the mice exhibited
THE (n ¼ 10, Fig. 2). As a competitive antagonist of GABAA/BZ,
ﬂumazenil signiﬁcantly reversed the protective effect of TMCA on
MES-induced convulsions. When pretreated with ﬂumazenil 5 mg/
kg, the incidence of THE increased from 20% to 90% in the mice
given with TMCA 20 mg/kg (n ¼ 10, P > 0.05), suggesting that
ﬂumazenil at 5 mg/kg signiﬁcantly antagonized the effects of
TMCA. Flumazenil injected with 1 mg/kg prior to TMCA 20 mg/kg
treatment lead the incidence of THE enhanced to 50% (P < 0.05)
(Fig. 2). These ﬁndings indicate that the GABAA/BZ receptor me-
diates the anti-convulsion effects of TMCA in this mouse MES
model.3.3. Anti-seizure property of TMCA in PTZ-induced seizure assessed
by behavioral evaluation
As a non-competitive antagonist of GABAA receptor, pentyl-
enetetrazol (PTZ) is often used to induce seizure in the animal
model of epilepsy. To investigate the anti-seizure effects of TMCA
on behavior, the behavioral seizure stage score and the latency to
onset of myoclonic jerks (MJ) and generalized clonic seizures (GCS)
were examined after PTZ injection. Within 30 min, PTZ caused a
sequence of characteristic behavioral symptoms such as tremor of
the vibrissae and muscles, MJ, GCS or GTCS followed by recovery or
some animals may succumb to death. Seizure latency prolongation
and stage decrease will be taken as index of protection. In the
vehicle-treatedmice, the latency toMJ and GCSwas 62.7 ± 5.5 s and
133.3 ± 17.5 s, respectively. The latency of MJ was signiﬁcantly
delayed to 118.2 ± 6.4 s and 182.3 ± 18.8 s by TMCA (10 and 20 mg/
kg) groups compared with the vehicle group (n ¼ 6, F(3, 23) ¼ 27.6,
P < 0.001) (Fig. 3A). Mice did not determined GCS behavioral in 10,
20 mg/kg of TMCA and 2 mg/kg of diazepam treated groups. TMCA
administered at 5 mg/kg did not cause any signiﬁcant change in the
latency to MJ, and to GCS in animals that display GCS behavioralFig. 2. Effect of pretreatment with ﬂumazenil on anti-seizure effect of TMCA in the
MES model. Flumazenil given at 0, 1 and 5 mg/kg attenuated the decrease in incidence
of tonic hindlimb extension (THE) caused by TMCA (n ¼ 10). *P < 0.05,**P < 0.01,
compared with the control group; #P < 0.05, compared with ﬂumazenil at 5 mg/kg
group (Fisher's exact test followed by bonferroni for correction).
Fig. 3. TMCA prolonged behavior seizure latency and decreased seizure stage in the
PTZ (60 mg/kg)-induced convulsions. (A) TMCA prolonged the latency to the onset of
myoclonic jerks (n ¼ 6) and (B) TMCA also decreased the mean seizure stage in the
model (n ¼ 6). Open, light gray, medium gray, dark gray, and dark bars stand for the
groups treated with vehicle, TMCA at doses of 5, 10, 20 mg/kg, and diazepam at 2 mg/
kg respectively. (C) Distributions of each stage after TMCA treatment. The divisions
within each bar are deﬁned above the bar graph (n ¼ 6). *P < 0.05, **P < 0.01, compared
with the vehicle group, as assessed by one-way ANOVA followed by LSD's test. Krus-
kaleWallis followed by Nemenyi test for seizure stage comparison.(n ¼ 5e6, P > 0.05) compared to vehicle. TMCA also signiﬁcantly
decreased the mean seizure stage (n ¼ 6, F(3, 23) ¼ 29.1, P < 0.001)
(Fig. 3B). The mean seizure stage was 4.3 ± 0.2 in vehicle-treated
group. TMCA given at 20 or 10 mg/kg, decreased the mean
seizure stage to 2.2 ± 0.17 (P < 0.01) or 2.3 ± 0.21 (P < 0.01),
respectively, compared to the vehicle (n ¼ 6, Fig. 3B). The stage-
distribution analysis (n ¼ 6, Fig. 3C) revealed that all vehicle-
treated mice developed GCS (stage 4), with turning to a side posi-
tion; and 33.3% of the mice also reached GTCS (stage 5) and died
within 30 min, the mortality rate is 33.3%, whereas none of the
TMCA-treated mice developed GTCS (stage 5). The incidence of
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was given at doses of both 10 and 20 mg/kg. However, TMCA
administered at 5 mg/kg did not cause any signiﬁcant change in the
mean seizure stage (n ¼ 6, P > 0.05) when compared to vehicle
(n ¼ 6, Fig. 3B). These results indicate that TMCA attenuated the
seizure severity and prolonged the latency of seizure onset in the
PTZ-induced seizure mouse model.
3.4. Involvement of the GABAA/BZ receptor in the anti-seizure effect
of TMCA in the PTZ-induced seizure model
As shown in Fig. 4, the latency to onset of MJ and GCS in mice
treated by vehicle plus 5 mg/kg ﬂumazenil was 54.7 ± 4 s (n ¼ 6,
P > 0.05) and 87 ± 8.8 s (n ¼ 6, P > 0.05), with 33.3% of the mice
died, which did not cause any signiﬁcant change in comparison
to vehicle treatment alone. Pretreatment with ﬂumazenil 5 mg/
kg completely antagonized the prolonged onset MJ latency as
well as the mean seizure stage that had been lowered by TMCA at
the 20 mg/kg dose. TMCA administered at 20 mg/kg did not
cause any signiﬁcant change in the latency to GCS compared to
vehicle when pretreated with ﬂumazenil 5 mg/kg, and 16.7% of
the mice even died. This suggests that the GABAA/BZ receptor is
involved in the anti-seizure effect of TMCA in the PTZ-induced
model.Fig. 4. Flumazenil antagonized the prolonged latency to myoclonic jerks (A, n ¼ 6) and gen
seizure model (C, n ¼ 6). (D) Distributions of each stage after TMCA at 20 mg/kg combined w
the bar graph (n ¼ 6). **P < 0.01, compared with the vehicle group; ##P < 0.01, compared w
KruskaleWallis followed by Nemenyi test for seizure stage comparison.4. Discussion
The results of the current study show that TMCA has anti-
seizure properties. The GABAA/BZ receptor antagonist, ﬂumazenil,
reversed these effects, indicating that TMCA may exert its anti-
seizure property through the GABAA/BZ receptor.
DMSO is an amphipathic molecule widely used to solubilize
water-insoluble compounds. DMSO could exert different effects on
seizure dependent on dosage. It was reported that low doses of
DMSO decreased whereas high doses of DMSO increased the
absence-like epileptic activity ofWAG/Rij rats (21). However, DMSO
at high doses (above 50%) also reduced the electrically induced
paroxysmal activity (22). In our present and previous reports, 0.5%
DMSO didn't shown signiﬁcant inﬂuence on MES or PTZ-induced
seizures.
Several in vivo and in vitro studies support our ﬁnding that
TMCA might elicit anti-seizure effects by acting on the GABAA/BZ
receptor complex. It was interesting that TMCA prolonged
pentobarbital-induced sleep behaviors, and these results were
similar to those of muscimol, a GABAA receptor agonist (7). TMCA
increased the activation of glutamic acid decarboxylase (GAD) and
the expressions of g-subunit of GABAA receptors in the cerebellar
granule cells and increases Cl-inﬂux (7). In agreement with previ-
ous experiments, we have found here that the anti-seizure effectseralized clonus (B, n ¼ 6) and increased the seizure stage reduced by TMCA in the PTZ
ith ﬂumazenil (0, 1, 5 mg/kg) treatment. The divisions within each bar are deﬁned above
ith ﬂumazenil at 5 mg/kg group, as assessed by two-way ANOVA followed by LSD's test.
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extract exerts rapid-onset antidepressant effects. Radix Polygalae
extract could decrease tail suspension tasks, and the immobility
reduction in tail suspension task was blocked by a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionicacid (AMPA) receptor
antagonist NBQX (23), suggesting TMCA may have modulatory
roles at glutamatergic synapses.
g-Aminobutyric acid (GABA) is the most prominent of the
inhibiting neurotransmitters in the brain. It exerts its main action
through GABAA receptors (24). GABAA receptor is an pentameric
assembly formed by 19 subunits in humans: a1-6, b1-3, g1-3, d, 3, p,
q and r1-3, and form chloride ion selective channels (25). Molecular
and genetic studies have revealed that BZs bind at the interface
between an a and g subunit of GABAA receptor, preferentially
enhancing synaptic receptors largely composed of a (1e3,5), b3,
and g2 subunits (26). Flumazenil is typically classiﬁed as a non-
selective BZ antagonist, acts at subunits a1, a2, a3, a5 and g2 or
partial agonist at subunits a4, a6 (27e29).
TMCA increased the expressions of g-subunit of GABAA re-
ceptors in the cerebellar granule cells (7). However, a- and b-sub-
units proteins of GABAA receptors were not increased (7). Recent
genetic studies revealed the importance of the mutations of GABAA
receptor g2 subunit in the development of febrile seizures (30e32).
The heterozygous mutation of GABAA g2 subunit was higher in
patients with febrile seizure (31). TMCA may exert anti-seizure
effects by regulating trafﬁcking or expression of g-subunit of
GABAA/BZ receptors. .
In a conclusion, TMCA may exerts anti-seizure effects through
interactions with the GABAA receptor complex.
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